Search
Menu
Home
HTB
2019
September
HTB
September 2019
Contents
Editorial
HTB 30 September 2019 online
Conference reports
10th IAS Conference on HIV Science (IAS 2019): final reports
Low rates of pregnancy with three methods of contraception in the ECHO trial
Other pregnancy studies IAS 2019
Antiretrovirals
Scotland approves dual therapy with dolutegravir/lamivudine (Dovato)
FDA expands indication for doravirine in the US as switch option
Treatment access
UK HIV organisations call for urgent review of crisis in sexual health funding
Guidelines
WHO update PrEP guidelines to include event-based dosing
UK issue joint guidelines on HIV discrimination in tattoo and beauty salons
Side effects
Greater weight gain with INSTI-based than non-INSTI-based ART among women in US cohort
Other news
UK is one of four EU countries to lose measles elimination status
On the web
Women and HIV research: free educational webcasts
PDFs
30 September 2019 vol 20 no 11
HTB RSS
Early access
Lenacapavir submitted to the US FDA with an indication for HIV PrEP
20 December 2024
i-Base guides updated online
5 December 2024
All early access reports
Current issues
December 2024
November 2024
October 2024
Back issues
Special report
Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan
9 November 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate